Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Levosimendan in septic shock in patients with biochemical evidence of cardiac dysfunction: a subgroup analysis of the LeoPARDS randomised trial.

Antcliffe DB, Santhakumaran S, Orme RML, Ward JK, Al-Beidh F, O'Dea K, Perkins GD, Singer M, McAuley DF, Mason AJ, Cross M, Ashby D, Gordon AC.

Intensive Care Med. 2019 Oct;45(10):1392-1400. doi: 10.1007/s00134-019-05731-w. Epub 2019 Aug 19.

PMID:
31428804
2.

Why Understanding Sepsis Endotypes Is Important for Steroid Trials in Septic Shock.

Antcliffe DB, Gordon AC.

Crit Care Med. 2019 Dec;47(12):1782-1784. doi: 10.1097/CCM.0000000000003833. No abstract available.

PMID:
31162195
3.

Transcriptomic Signatures in Sepsis and a Differential Response to Steroids. From the VANISH Randomized Trial.

Antcliffe DB, Burnham KL, Al-Beidh F, Santhakumaran S, Brett SJ, Hinds CJ, Ashby D, Knight JC, Gordon AC.

Am J Respir Crit Care Med. 2019 Apr 15;199(8):980-986. doi: 10.1164/rccm.201807-1419OC.

4.

Profiling inflammatory markers in patients with pneumonia on intensive care.

Antcliffe DB, Wolfer AM, O'Dea KP, Takata M, Holmes E, Gordon AC.

Sci Rep. 2018 Oct 3;8(1):14736. doi: 10.1038/s41598-018-32938-6.

Supplemental Content

Loading ...
Support Center